AbCellera Biologics盘前交易中股价大幅上涨30.5%，这得益于其一款实验性药物在中期临床试验中成功减少了患者的热潮现象。该试验结果令市场投资者信心大增，推动了公司股价的显著攀升。
AbCellera Biologics盘前交易中股价大幅上涨30.5%，这得益于其一款实验性药物在中期临床试验中成功减少了患者的热潮现象。该试验结果令市场投资者信心大增，推动了公司股价的显著攀升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.